Literature DB >> 3788973

The incidence and gene frequency of ataxia-telangiectasia in the United States.

M Swift, D Morrell, E Cromartie, A R Chamberlin, M H Skolnick, D T Bishop.   

Abstract

Ataxia-telangiectasia (A-T) is an autosomal recessive neurological syndrome of considerable interest because homozygotes are highly predisposed to cancer. Vigorous casefinding in the United States in 1970-72 and 1980-84 identified 231 white, 29 black, and three Oriental A-T cases that provide information about the incidence and gene frequency of A-T. White patients identified in this study were born at the rate of 3.0 per million live births in the U.S. in the years 1965-69. The highest observed incidence was in the state of Michigan for 1965-69, where identified white A-T patients were born at the rate of 11.3 per million births. Based on the incidence data, the minimum frequency of a single hypothetical A-T gene in the U.S. white population was estimated to be .0017. Pedigree analysis, which estimates the gene frequency from the proportion of affected close blood relatives of homozygous probands, estimated the most likely gene frequency to be .007 on the assumption that A-T is a single homogeneous genetic syndrome, with 95% confidence limits of .0012-.02. Given that complementation analysis has demonstrated the genetic heterogeneity of A-T, the A-T heterozygote frequency will probably fall between 0.68% and 7.7%, with 2.8% being the most likely estimate.

Entities:  

Mesh:

Year:  1986        PMID: 3788973      PMCID: PMC1684065     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  9 in total

1.  Complementation analysis of ataxia-telangiectasia.

Authors:  N G Jaspers; R B Painter; M C Paterson; C Kidson; T Inoue
Journal:  Kroc Found Ser       Date:  1985

2.  Effect of synthetic gonadotrophin-releasing hormone in secondary amenorrhoea.

Authors:  E O Akande; J Bonnar; P J Carr; C S Corker; A Dutton; P C MacKinnon; D Robinson
Journal:  Lancet       Date:  1972-07-15       Impact factor: 79.321

3.  A general model for the genetic analysis of pedigree data.

Authors:  R C Elston; J Stewart
Journal:  Hum Hered       Date:  1971       Impact factor: 0.444

4.  Cancer in families with xeroderma pigmentosum.

Authors:  M Swift; C Chase
Journal:  J Natl Cancer Inst       Date:  1979-06       Impact factor: 13.506

5.  Ataxia-telangiectasia and Swiss-type agammaglobulinemia. Two genetic disorders of the immune mechanism in related Amish sibships.

Authors:  V A McKusick; H E Cross
Journal:  JAMA       Date:  1966-02-28       Impact factor: 56.272

6.  Malignant neoplasms in the families of patients with ataxia-telangiectasia.

Authors:  M Swift; L Sholman; M Perry; C Chase
Journal:  Cancer Res       Date:  1976-01       Impact factor: 12.701

7.  The natural history of homocystinuria due to cystathionine beta-synthase deficiency.

Authors:  S H Mudd; F Skovby; H L Levy; K D Pettigrew; B Wilcken; R E Pyeritz; G Andria; G H Boers; I L Bromberg; R Cerone
Journal:  Am J Hum Genet       Date:  1985-01       Impact factor: 11.025

8.  Mortality and cancer incidence in 263 patients with ataxia-telangiectasia.

Authors:  D Morrell; E Cromartie; M Swift
Journal:  J Natl Cancer Inst       Date:  1986-07       Impact factor: 13.506

9.  Reassessment of cancer predisposition of Fanconi anemia heterozygotes.

Authors:  M Swift; R J Caldwell; C Chase
Journal:  J Natl Cancer Inst       Date:  1980-11       Impact factor: 13.506

  9 in total
  84 in total

1.  Haplotypes at ATM identify coding-sequence variation and indicate a region of extensive linkage disequilibrium.

Authors:  P E Bonnen; M D Story; C L Ashorn; T A Buchholz; M M Weil; D L Nelson
Journal:  Am J Hum Genet       Date:  2000-11-14       Impact factor: 11.025

2.  Abnormal white matter signal in ataxia telangiectasia.

Authors:  J J Ciemins; A L Horowitz
Journal:  AJNR Am J Neuroradiol       Date:  2000-09       Impact factor: 3.825

3.  Characterisation of ATM mutations in Slavic Ataxia telangiectasia patients.

Authors:  Jana Soukupova; Petr Pohlreich; Eva Seemanova
Journal:  Neuromolecular Med       Date:  2011-08-11       Impact factor: 3.843

Review 4.  Radiological imaging in ataxia telangiectasia: a review.

Authors:  Ishani Sahama; Kate Sinclair; Kerstin Pannek; Martin Lavin; Stephen Rose
Journal:  Cerebellum       Date:  2014-08       Impact factor: 3.847

5.  Heterogeneity in the clastogenic response to X-rays in lymphocytes from ataxia-telangiectasia heterozygotes and controls.

Authors:  J K Wiencke; D W Wara; J B Little; K T Kelsey
Journal:  Cancer Causes Control       Date:  1992-05       Impact factor: 2.506

6.  The relative biological effectiveness of densely ionizing heavy-ion radiation for inducing ocular cataracts in wild type versus mice heterozygous for the ATM gene.

Authors:  Eric J Hall; Basil V Worgul; Lubomir Smilenov; Carl D Elliston; David J Brenner
Journal:  Radiat Environ Biophys       Date:  2006-06-24       Impact factor: 1.925

7.  Neurological and cytogenetic study in early-onset ataxia-telangiectasia patients.

Authors:  V Leuzzi; R Elli; A Antonelli; L Chessa; F Cardona; L Marcucci; P Petrinelli
Journal:  Eur J Pediatr       Date:  1993-07       Impact factor: 3.183

8.  Cranial MRI in ataxia-telangiectasia.

Authors:  F Sardanelli; R C Parodi; C Ottonello; P Renzetti; S Saitta; E Lignana; G L Mancardi
Journal:  Neuroradiology       Date:  1995-01       Impact factor: 2.804

9.  p53 centrosomal localization diagnoses ataxia-telangiectasia homozygotes and heterozygotes.

Authors:  Andrea Prodosmo; Andrea De Amicis; Cecilia Nisticò; Mario Gabriele; Giuliana Di Rocco; Laura Monteonofrio; Maria Piane; Enrico Cundari; Luciana Chessa; Silvia Soddu
Journal:  J Clin Invest       Date:  2013-02-01       Impact factor: 14.808

10.  Ataxia telangiectasia: learning from previous mistakes.

Authors:  Naveen Kumar; Puneet Aggarwal; Nishanth Dev; Gunjan Kumar
Journal:  BMJ Case Rep       Date:  2012-12-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.